USE OF COPULAS FOR CORRELATED SAMPLING OF COST AND UTILITY PARAMETERS DURING PROBABILISTIC SENSITIVITY ANALYSIS FOR COST-EFFECTIVENESS ANALYSES

被引：0
作者：
Lim, S. [1 ]
LoPresti, M. [2 ]
Murofushi, T. [3 ]
机构：
[1] IINTAGE Healthcare Inc, Kawasaki 14, Japan
[2] IINTAGE Healthcare Inc, Tokyo 14, Japan
[3] INTAGE Healthcare Inc, Tokyo 13, Japan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE589
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
[41]   Challenges and Opportunities for Use of Cost-Effectiveness Analysis [J].
Yabroff, K. Robin ;
Schrag, Deborah .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (17) :1161-U11
[42]   THE USE OF DALYS AND QALYS IN COST-EFFECTIVENESS ANALYSIS [J].
Deshmukh, A. A. ;
Chen, A. ;
Sonawane, K. B. ;
Cantor, S. B. .
VALUE IN HEALTH, 2013, 16 (03) :A270-A270
[43]   POTENTIAL INCONSISTENCIES BETWEEN COST-EFFECTIVENESS AND COST-UTILITY ANALYSES - AN UPSTAIRS DOWNSTAIRS SOCIOECONOMIC DISTINCTION [J].
RITTENHOUSE, BE .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1995, 11 (02) :365-376
[44]   What is known about the cost-effectiveness of orphan drugs? Evidence from cost-utility analyses [J].
Picavet, E. ;
Cassiman, D. ;
Simoens, S. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (03) :304-307
[45]   Behind the Numbers: Sensitivity Analysis in Cost-Effectiveness Modeling [J].
Halpern, Elkan F. ;
Pandharipande, Pari V. .
RADIOLOGY, 2017, 284 (02) :310-312
[46]   Sensitivity Analysis in Cost-Effectiveness StudiesFrom Guidelines to Practice [J].
Rahul Jain ;
Michael Grabner ;
Eberechukwu Onukwugha .
PharmacoEconomics, 2011, 29 :297-314
[47]   Lithium use during pregnancy for bipolar disorder: a cost-effectiveness analysis [J].
Saito, Tanya ;
Boone, Ryan ;
Hersh, Alyssa R. ;
Caughey, Aaron B. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) :S738-S738
[48]   How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses? [J].
Yaesoubi, Reza .
VALUE IN HEALTH, 2024, 27 (11) :1553-1563
[49]   Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis [J].
Sloan, FA ;
WhettenGoldstein, K ;
Wilson, A .
SOCIAL SCIENCE & MEDICINE, 1997, 45 (04) :523-533
[50]   Cost-effectiveness analysis of axitinib through a probabilistic decision model [J].
Petrou, Panagiotis .
EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (08) :1233-1243
12345